S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

BRTX BioRestorative Therapies Inc

1.75

0.0203 (1.17%)

Apr 17 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

BioRestorative Therapies (NASDAQ:BRTX)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more BioRestorative Therapies Charts.

BioRestorative Therapies (NASDAQ:BRTX)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more BioRestorative Therapies Charts.

BioRestorative Therapies Inc News

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities
Tuesday 15 April 2025 (3 days ago) • GlobeNewswire Inc.

BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States
Thursday 10 April 2025 (1 week ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 27 March 2025 (3 weeks ago) • Edgar (US Regulatory)

BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
Thursday 27 March 2025 (3 weeks ago) • GlobeNewswire Inc.

BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025
Thursday 20 March 2025 (4 weeks ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 28 February 2025 (2 months ago) • Edgar (US Regulatory)

BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
Thursday 27 February 2025 (2 months ago) • GlobeNewswire Inc.

BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update
Wednesday 26 February 2025 (2 months ago) • GlobeNewswire Inc.

BioRestorative to Provide a Positive FDA Update on Clinical Pipeline
Tuesday 25 February 2025 (2 months ago) • GlobeNewswire Inc.

BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program
Thursday 20 February 2025 (2 months ago) • GlobeNewswire Inc.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 19 February 2025 (2 months ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 19 February 2025 (2 months ago) • Edgar (US Regulatory)

More BioRestorative Therapies Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions